What markers track oxidative stress?

What markers track oxidative stress?

Oxidative stress is a research construct, not a single analyte, and the registered studies that address it do not converge on one marker. Across the trials cited here, the readouts named are glutathione and malondialdehyde concentrations in blood cells, GPX4 expression in bowel tissue, and oxidative-stress status inferred from antioxidant-supplementation endpoints in defined patient populations [1][5][7]. No single marker is used as a universal index; each study pairs a marker with a specific tissue, model or clinical population.

The mechanistic centre of this work is redox balance — the relationship between reactive oxygen species generation and the glutathione-dependent and enzymatic antioxidant systems that oppose it. Several of the compounds discussed below are studied precisely because they are proposed to act on that balance: N-acetylcysteine as an anti-oxidative-stress and neuroprotective agent, zinc as a cofactor for Cu/Zn-superoxide dismutase, and vitamin E as a lipophilic antioxidant adjunct [1][2][4].

Research Studies

Glutathione and malondialdehyde in low-level light therapy, healthy adults versus type 1 diabetes

A registered trial evaluates low-level light therapy in healthy adults and in patients with type 1 diabetes, with oxidative stress markers specified as glutathione and malondialdehyde concentrations, alongside adenosine triphosphate levels and cytochrome c oxidase activity in blood cells [7]. Blood samples are compared before and after the intervention to assess whether mitochondrial function is altered, and the responses of healthy volunteers are compared with those of diabetic participants [7]. This is a human study design; the evidence block reports the planned markers and comparison, not results.

GPX4 expression after Kono-S versus conventional anastomosis in Crohn's disease

In Crohn's disease, many patients require surgery to remove damaged intestine, and recurrence near the anastomosis is common [5]. A registered project compares the Kono-S anastomosis with conventional reconnection and examines how the bowel heals by looking at oxidative stress, with GPX4 expression as the named readout [5]. The rationale given is that early results for Kono-S are promising but the mechanism is not fully understood [5]. This is a human surgical-cohort study; no outcome data are reported in the evidence block.

Vitamin E add-on therapy and thyroid function in levothyroxine-treated hypothyroidism

A registered study asks whether vitamin E supplementation as an adjunct to levothyroxine therapy reduces oxidative stress, improves antioxidant defence mechanisms, and favourably influences thyroid hormone status in patients with hypothyroidism [1]. The stated aim is to establish an evidence-based framework for integrating targeted antioxidant therapies into standard hypothyroid management [1]. The population is levothyroxine-treated hypothyroid patients; the evidence block describes the objective, not findings.

Zinc supplementation, insulin resistance and Cu/Zn-superoxide dismutase in women with PMOS

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is described as the most common endocrinopathy in women of reproductive age, mechanistically anchored in insulin resistance and driving hyperandrogenism, anovulation, dyslipidaemia and long-term type 2 diabetes risk [2]. South Asian women, including Bangladeshi women, are reported to develop insulin resistance at lower BMI thresholds than other populations while carrying one of the world's highest burdens of zinc deficiency, at 57% of non-pregnant non-lactating women [2]. Zinc is described as structurally required for pancreatic β-cell insulin synthesis, as modulating insulin-receptor signalling and PI3K/Akt-mediated glucose uptake, and as a cofactor for Cu/Zn-superoxide dismutase [2]. The registered study examines zinc supplementation against insulin resistance and clinical features in this population [2].

N-acetylcysteine and repetitive or self-injurious behaviour in Cornelia de Lange syndrome

A randomized cross-over pilot trial tests N-acetylcysteine (NAC) for repetitive behaviours and self-injurious behaviour in patients with Cornelia de Lange syndrome (CdLS) [4]. NAC is described as a known anti-oxidative-stress and neuroprotective agent that has been shown to decrease the occurrence of self-injurious behaviour such as skin picking, and as showing partial response in trials for compulsive behaviours in obsessive-compulsive disorder and related disorders in autism [4]. CdLS is a genetic disorder with autistic features including repetitive and self-injurious behaviours [4]. The population is patients with CdLS; the evidence block reports the trial design and prior observations, not this trial's results.

Nicotinamide riboside and walking distance in peripheral artery disease

The NICE-PAD II trial randomizes 250 participants with peripheral artery disease (PAD) aged 50 and older to nicotinamide riboside (NR) or placebo for six months [3]. The primary outcome is change in six-minute walk distance at six-month follow-up, with secondary outcomes including Walking Impairment Questionnaire distance score, PROMIS Mobility score, and calf muscle perfusion measured by magnetic resonance arterial spin labelling [3]. The hypothesis tested is that participants randomized to NR will show greater improvement or less decline in six-minute walk distance than those randomized to placebo [3]. The population is adults aged 50 and older with PAD.

Oral melatonin as adjunctive therapy in adults with atopic dermatitis

A randomized controlled trial evaluates oral melatonin as an adjunct to standard treatment in adults with atopic dermatitis, a chronic inflammatory skin disease associated with itching, sleep disturbance and impaired quality of life [6]. Melatonin is described as potentially having beneficial effects on sleep, inflammation and oxidative stress [6]. A total of 130 participants are randomly assigned 1:1 to standard treatment per the Vietnamese Ministry of Health 2023 guideline, or standard treatment plus oral melatonin 6 mg once daily for four weeks [6]. Severity is assessed using the SCORing Atopic Dermatitis instrument [6]. The population is adults with atopic dermatitis.

Vitamin D and oxidative stress in diabetic peripheral neuropathy

Diabetic peripheral neuropathy (DPN) is described as among the most common chronic complications of diabetes mellitus and a major cause of morbidity, impaired quality of life, sleep disturbance, chronic pain and functional disability [8]. Its pathogenesis is described as multifactorial, involving oxidative stress, chronic inflammation, endothelial dysfunction, mitochondrial injury and microvascular ischaemia, leading to progressive nerve damage [8]. Despite symptomatic therapies such as gabapentin, pregabalin and duloxetine, many patients continue to experience persistent neuropathic symptoms, poor sleep quality and impaired daily function [8]. The registered study concerns vitamin D in this population [8].

Comparison of named oxidative stress readouts across registered studies

Supporting mechanistic observations from preclinical and review literature

Several reference-only sources bear on how oxidative stress markers are interpreted. A study of cardiac aging reported that ALKBH5-dependent m6A demethylation promotes cardiac aging through SLC38A3 reduction and altered glutamine metabolism [9]. Work on mitochondrial peptide SHLP2 reported that it limits poly(I:C)-induced alveolar epithelial injury by modulating redox, apoptotic, inflammatory and inflammasome responses in type II alveolar epithelial cells [10]. A scoping review examined coffee and coffee-derived bioactive compounds — caffeine, (poly)phenols, trigonelline and diterpenes — in relation to skeletal muscle health, noting that the relationship remains incompletely understood despite associations between habitual coffee consumption and metabolic benefit [11]. A further review treats ergothioneine as a diet-derived xenobiotic, covering OCTN1-mediated disposition and mitochondrial redox regulation, and notes that inconsistent results in conventional antioxidant trials are likely attributable to multiple factors including compound selection and dose [12]. These are mechanistic and review-level contributions; they are not clinical marker-validation studies.

If you are reading this for personal health reasons

The materials described here are sold for laboratory research only, and we do not provide dosing or medical guidance. Nothing on this page is a recommendation to take any compound. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] Vitamin E Add-On Therapy, Thyroid Function & Oxidative Stress in Levothyroxine-Treated Hypothyroidism — https://clinicaltrials.gov/study/NCT07781514
• [2] Effect of Zinc Supplementation on Insulin Resistance and Clinical Features in Women With Polyendocrine Metabolic Ovarian Syndrome — https://clinicaltrials.gov/study/NCT07801001
• [3] The NICE-PAD II Trial — https://clinicaltrials.gov/study/NCT07782671
• [4] Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome — https://clinicaltrials.gov/study/NCT04381897
• [5] GPX4 Expression After Kono-S vs Conventional Anastomosis — https://clinicaltrials.gov/study/NCT07772037
• [6] Oral Melatonin as Adjunctive Therapy in Adults With Atopic Dermatitis — https://clinicaltrials.gov/study/NCT07842900
• [7] The Effect of Light Therapy on Cellular Energy and Oxidative Stress in Healthy Adults and Type 1 Diabetic Patients — https://clinicaltrials.gov/study/NCT07833865
• [8] Vitamin D in Diabetic Neuropathy — https://clinicaltrials.gov/study/NCT07644520
• [9] ALKBH5-Dependent m6A Demethylation Promotes Cardiac Aging Through SLC38A3 Reduction and Glutamine Metabolic Alteration — https://pubmed.ncbi.nlm.nih.gov/42770216/
• [10] Mitochondrial Peptide SHLP2 Limits Poly(I:C)-Induced Alveolar Epithelial Injury by Modulating Redox, Apoptotic, Inflammatory, and Inflammasome Responses — https://pubmed.ncbi.nlm.nih.gov/42774487/
• [11] Coffee and coffee-derived bioactive compounds in skeletal muscle health: a scoping review of mechanistic pathways, preclinical evidence and human outcomes — https://pubmed.ncbi.nlm.nih.gov/42626818/
• [12] Ergothioneine as a diet-derived xenobiotic: OCTN1-mediated disposition, mitochondrial redox regulation, and emerging implications for cardiovascular disease — https://pubmed.ncbi.nlm.nih.gov/42764404/